Latest Strategy News

Auckland Airport posted a 3% revenue increase and a stable underlying profit of NZD 309 million in FY26, driven by robust passenger growth and a $1 billion infrastructure push, while cautioning on near-term fuel price volatility and geopolitical risks.

Audalia Resources has raised $450,000 through a placement of 15 million shares at 3 cents each, aiming to push the Medcalf project towards production while maintaining working capital.

Energy Fuels Inc. reported a transformative 2024 with a major acquisition boosting its heavy mineral sands assets, a uranium production ramp-up at key US mines, and commercial rare earth oxide output from its White Mesa Mill.

Ironbark Balanced Income Limited reported a 5.6% decline in net profit to $2.89 million for FY2026, while its investment portfolio delivered a solid 7.8% return, outperforming its benchmark and maintaining fully franked dividends.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.

Recce Pharmaceuticals has secured ethics approval to add an active-controlled arm to its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, enabling head-to-head comparison against existing antibiotics.

ReNerve Ltd (ASX:RNV) reported an 80% year-on-year revenue increase in Q4 FY26, backed by expanding product lines and a $5 million funding facility. The company is advancing FDA approvals and growing its global distribution footprint, targeting a rapidly expanding $6.19 billion nerve repair biomaterials market.

Canadian Phosphate Limited’s initial 2026 drilling at Wapiti has successfully intersected phosphate mineralisation in all eight holes, extending the known Main Zone strike by over 3km. Assay results are pending, with a resource update planned for late 2026.

Magnum Mining has completed nearly 7,000m of drilling at its Piracanjuba North rare earth project, expanding its footprint ahead of a planned November resource estimate, while assay results from Palmares await interpretation amid a strategic portfolio review.

Mount Ridley Mines has lodged a provisional patent for its SelectroTM hydrometallurgical leach technology, demonstrating superior recoveries of rare earths, scandium, and gallium compared to conventional methods. The company is advancing testwork and commercial discussions to capitalise on the innovation.

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.